Anavex Life Sciences
AVXL
AVXL
181 hedge funds and large institutions have $270M invested in Anavex Life Sciences in 2025 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 59 increasing their positions, 44 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.1% more ownership
Funds ownership: 34.84% → 36.93% (+2.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
15% less capital invested
Capital invested by funds: $316M → $270M (-$46.6M)
Holders
181
Holding in Top 10
1
Calls
$14.7M
Puts
$8.92M
Top Buyers
| 1 | +$6.88M | |
| 2 | +$3.88M | |
| 3 | +$2.35M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.9M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.62M |
Top Sellers
| 1 | -$3.97M | |
| 2 | -$3.25M | |
| 3 | -$2.98M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.06M |
| 5 |
Renaissance Technologies
New York
|
-$1.71M |